Skip to content

CYCLO THERAPEUTICS, INC.

CIK 0000922247

← back to feed
Revenue (TTM)
$1.62M
+62.1% YoY Q3 Nov 2024
Net Income (TTM)
−$23.93M
−29.8% YoY Q3 Nov 2024
EPS Diluted (TTM)
—
Q3 Nov 2024
Gross Margin
60.3%
Q3 Nov 2024
Operating Margin
-1,473.2%
Q3 Nov 2024
Net Margin
-1,480.3%
Q3 Nov 2024
Free Cash Flow (TTM)
−$20.36M
Q3 Nov 2024
Cash
$928.01K
Q3 Nov 2024
Total Debt
$821.12K
Q3 Nov 2024
Shares Outstanding
28.77M sh
Q3 Nov 2024

Revenue & Net Income

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings